# MAGNET-seq: A tandem PCR and hybrid capture method for enhanced target enrichment

**Authors:** Dongin Lee, Taehoon Kim, Duhee Bang

PMC · DOI: 10.1371/journal.pone.0325385 · PLOS One · 2025-06-04

## TL;DR

MAGNET-seq is a new method that combines PCR and hybrid capture to improve sequencing efficiency for specific genomic regions, especially useful for detecting low-frequency mutations in cancer.

## Contribution

MAGNET-seq introduces a streamlined method integrating PCR and hybrid capture for enhanced target enrichment and detection of low-allele frequency variants.

## Key findings

- MAGNET-seq achieved an average on-target ratio of 86.2% compared to 2.2% with standard PCR.
- It demonstrated reproducible variant allele frequencies in low-VAF cell-free DNA samples.
- The method is cost-efficient and suitable for detecting somatic cancer mutations.

## Abstract

Hybrid-capture based target enrichment and multiplex PCR methods enhance sequencing efficiency by focusing on specific genomic regions, while struggling to enrich tens of regions spanning hundreds to thousands of base pairs. We developed MAGNET-seq (Multiplex Amplification and tarGeted eNrichment of sElecTed sequences), a streamlined method that integrates targeted multiplex PCR with hybrid capture. We evaluated its performance using two primer sets: a Drug Resistance Targeting Primers with 43 targets and a Reference Primers set with 7 targets, including clinically relevant mutations such as EGFR c.2369C > T (p.T790M) and KRAS c.35G > T (p.G12C). Using a set of 43 target primers, MAGNET-seq demonstrated higher on-target ratios (average 86.2%) compared to standard targeted multiplex PCR (average 2.2%). Furthermore, MAGNET-seq with 7 target primers showed concordant variant allele frequencies (VAF) in low-VAF (≤ 1%) reference cell-free DNA (cfDNA) samples (0.05% to 1%), supporting its reproducibility. This approach provides a simplified and cost-efficient solution for targeted sequencing, particularly well-suited for applications that require detection of low-allele frequency variants such as somatic cancer mutations.

## Linked entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956], KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845]

## Full-text entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}
- **Diseases:** cancer (MESH:D009369)
- **Mutations:** c.35G > T, p.T790M, p.G12C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12136444/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12136444/full.md

## References

73 references — full list in the complete paper: https://tomesphere.com/paper/PMC12136444/full.md

---
Source: https://tomesphere.com/paper/PMC12136444